BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
+12.27%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.41B
AUM Growth
+$360M
(+18%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
6.53%
Top 10 Holdings %
Top 10 Hldgs %
42.18%
Holding
187
New
25
Increased
60
Reduced
55
Closed
15
Top Buys
| 1 |
Moderna
MRNA
|
+$30.4M |
| 2 |
Estee Lauder
EL
|
+$20.1M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$18.1M |
| 4 |
Eli Lilly
LLY
|
+$17.3M |
| 5 |
PepsiCo
PEP
|
+$14.2M |
Top Sells
| 1 |
Vanguard Value ETF
VTV
|
+$13.2M |
| 2 |
UnitedHealth
UNH
|
+$10.7M |
| 3 |
3M
MMM
|
+$7.93M |
| 4 |
Chevron
CVX
|
+$7.44M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$6.37M |
Sector Composition
| 1 | Healthcare | 24.97% |
| 2 | Technology | 17.74% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Communication Services | 10.58% |
| 5 | Financials | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Neogen
NEOG
$1.19B
| $1.33M | 0.06% |
71,950
+4,400
| +7% | +$81.5K |
|
102
Gilead Sciences
GILD
$142B
| $1.25M | 0.05% |
15,075
-950
| -6% | -$78.8K |
|
103
SOPHiA GENETICS
SOPH
$211M
| $1.13M | 0.05% |
227,600
| – | – |
|
104
Walmart
WMT
$825B
| $1.12M | 0.05% |
22,800
| – | – |
|
105
Constellation Brands
STZ
$24.6B
| $1.03M | 0.04% |
4,548
| – | – |
|
106
Biogen
BIIB
$21.2B
| $1,000K | 0.04% |
3,596
-264
| -7% | -$73.4K |
|
107
Becton Dickinson
BDX
$53.6B
| $990K | 0.04% |
4,000
| – | – |
|
108
Boston Scientific
BSX
$152B
| $964K | 0.04% |
19,278
+563
| +3% | +$28.2K |
|
109
Verizon
VZ
$185B
| $899K | 0.04% |
23,125
-13,100
| -36% | -$509K |
|
110
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.81B
| $859K | 0.04% |
+20,908
| New | +$859K |
|
111
Logitech
LOGI
$16B
| $845K | 0.04% |
14,534
-1,000
| -6% | -$58.1K |
|
112
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
| $792K | 0.03% |
+8,677
| New | +$792K |
|
113
Enphase Energy
ENPH
$4.92B
| $782K | 0.03% |
+3,721
| New | +$782K |
|
114
Bristol-Myers Squibb
BMY
$94B
| $780K | 0.03% |
11,250
| – | – |
|
115
Vanguard FTSE Emerging Markets ETF
VWO
$100B
| $775K | 0.03% |
+19,189
| New | +$775K |
|
|
AMED
116
DELISTED
Amedisys
AMED
| $772K | 0.03% |
10,491
+628
| +6% | +$46.2K |
|
|
GB
117
DELISTED
Global Blue Group Holding
GB
| $771K | 0.03% |
128,571
| – | – |
|
118
IBM
IBM
$236B
| $768K | 0.03% |
5,860
| – | – |
|
119
Lockheed Martin
LMT
$110B
| $756K | 0.03% |
1,600
| – | – |
|
120
Vertex Pharmaceuticals
VRTX
$101B
| $732K | 0.03% |
2,323
+442
| +23% | +$139K |
|
121
TJX Companies
TJX
$155B
| $695K | 0.03% |
8,869
| – | – |
|
122
Edwards Lifesciences
EW
$45.5B
| $678K | 0.03% |
8,194
| – | – |
|
123
Stryker
SYK
$147B
| $665K | 0.03% |
2,329
-212
| -8% | -$60.5K |
|
124
Rockwell Automation
ROK
$38.8B
| $640K | 0.03% |
+2,181
| New | +$640K |
|
125
Natera
NTRA
$23.1B
| $617K | 0.03% |
11,118
+139
| +1% | +$7.72K |
|